Public Health
Latest news
417 articles · 20 / page
Enhanced Protection in Heart Failure: High-Dose Influenza Vaccine Outperforms Standard Dose in the DANFLU-2 Trial
The DANFLU-2 trial reveals that high-dose influenza vaccine significantly reduces hospitalization for influenza and cardiovascular events in older adults, including those with heart failure, compared to the standard-dose vaccine.
PANDA II Trial Confirms Influenza Vaccination as Essential Intervention for Acute Heart Failure Patients
The PANDA II study demonstrates that influenza vaccination significantly reduces mortality and rehospitalization in acute heart failure patients, supporting its inclusion as a standard component of heart failure management worldwide.
Azelastine Nasal Spray Significantly Reduces SARS-CoV-2 Infection Risk: Results from a Phase 2 Randomized Clinical Trial
This phase 2 trial demonstrates that azelastine nasal spray reduces SARS-CoV-2 infections and symptomatic respiratory illnesses in a healthy, vaccinated adult population, suggesting its potential as a safe, scalable prophylactic measure aga
Evaluating RSV Vaccine Effectiveness Against Hospitalization in US Adults Aged 60 and Older Over Two Seasons
A large multicenter study demonstrates that a single dose of RSV vaccine reduces hospitalization risk by 58% among adults aged 60+, with lower effectiveness in immunocompromised and cardiovascular patients.
Bivalent RSV Prefusion F Protein Vaccine: A Potential Strategy to Reduce Cardiovascular Hospitalizations in Older Adults
The DAN-RSV trial demonstrates that RSV vaccination significantly lowers all-cause cardiorespiratory hospitalizations among older adults, suggesting vaccines may reduce infection-triggered cardiovascular complications and benefit chronic di
Invisible Invaders: How Microplastics Penetrate Our Bodies and What You Can Do About It
Microplastics, tiny plastic particles under 5mm, have silently infiltrated our bodies through drinking water, air, and food. They accumulate in organs, accelerate cell aging, and increase inflammation. Learn hidden sources and practical tip
Invisible Intruders: Microplastics Found in Every Human Placenta Sample Tested
Recent research shows microplastics present in 100% of 62 human placentas analyzed, raising concerns about prenatal exposure and future health implications.
Microwaving Plastic Containers: A Hidden Source of Billions of Microplastic Particles in Your Food
Recent research reveals that microwaving plastic food containers can release billions of micro- and nanoplastic particles into food, posing potential health risks, especially to infants and young children. Understanding this silent contamin
FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults
The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving
Persistent Medical Debt After Cancer Diagnosis: Insights from a Large Massachusetts Cohort Study
A Massachusetts cohort study reveals modest but persistent increases in medical debt after cancer diagnosis, particularly in colorectal and bladder cancers, despite high insurance coverage. Total debt, bankruptcy rates, and credit scores re
High-Dose Influenza Vaccines Cut Hospitalizations: Landmark Trials Shape Cardiovascular Prevention
Two massive randomized trials show high-dose flu vaccines reduce influenza-related and cardiorespiratory hospitalizations in older adults, reinforcing vaccination as a vital cardiovascular prevention strategy.
Unraveling Chronic Stress: The Role of Gut Dysbiosis and Vitamin B6 Metabolism in Stress-Related Brain Disorders Independent of Cortisol
Recent evidence reveals gut dysbiosis-induced vitamin B6 metabolic disturbances as a novel, cortisol-independent mechanism driving chronic stress-related abnormal behaviors and inflammation, highlighting probiotic and vitamin B6 supplementa
Enhancing Early Risk Stratification of Severe Childhood Febrile Illness in Rural Asia Using sTREM1 Biomarker
A multicountry study across Asia demonstrates soluble TREM1’s superior accuracy over traditional clinical signs in predicting severe febrile illness in children, potentially transforming triage in resource-limited settings.
Ventilation Hoods During Cooking Significantly Reduce PM2.5 Exposure and Improve Cardiometabolic and Pulmonary Health: Evidence from a Cluster-Randomized Trial in Rural China
A community-based intervention using ventilation hoods during cooking reduced 24-hour PM2.5 exposure by nearly 30% and improved cardiometabolic and pulmonary health markers in rural Chinese villages reliant on wood fuel.
Promising Immunogenicity and Safety of the Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers
This phase I/II trial demonstrates that the live-attenuated intranasal RSV vaccine (RSVt) is immunogenic and well-tolerated in infants and toddlers, offering a potential new preventive option against RSV infection.
Evaluating Community-Wide Mass Drug Administration to Interrupt Soil-Transmitted Helminth Transmission: Insights from the DeWorm3 Trial
The DeWorm3 trial assessed whether high-coverage community-wide mass drug administration with albendazole could interrupt soil-transmitted helminth transmission in Benin, India, and Malawi but found limited success, suggesting tailored appr
The Slowing Pace of Longevity: Why Today’s Generations May Not Reach 100 Years
Recent research reveals a significant slowdown in life expectancy growth, suggesting that contemporary generations may not achieve the rapid longevity gains of the past or routinely reach 100 years.
Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial
This review synthesizes trial evidence showing that nicotine-containing e-cigarettes modestly improve lipid profiles but cause no significant changes in lung function or other cardiovascular markers compared to cigarette substitutes in smok
Cytisinicline’s Promise in Smoking Cessation: Insights from the ORCA Phase 3 Replication Trial
The ORCA-3 trial confirms cytisinicline’s efficacy and safety for smoking cessation at 6 and 12 weeks, showing sustained abstinence and reduced nicotine craving up to 24 weeks.
Varenicline Significantly Enhances Nicotine Vaping Cessation in Youth: Insights from a Landmark Randomized Clinical Trial
A randomized clinical trial demonstrates that varenicline, combined with behavioral counseling, markedly improves nicotine vaping cessation rates in youth aged 16-25 who vape daily and do not regularly smoke tobacco.
Browse by specialty
Open language-specific specialty feeds and department pages.